Protein kinase inhibitors: Current strategies and future prospects

Caballero, J

Keywords: apoptosis, crystal, inhibition, enzyme, weight, transcription, binding, kidney, protein, proliferation, cell, design, structure, carcinoma, transition, cancer, metabolism, site, humans, transduction, lung, leukemia, human, inhibitor, signal, kinases, drug, molecular, inhibitors, kinase, angiogenesis, breast, genetic, chronic, gefitinib, small, editorial, tracer, imatinib, sunitinib, nilotinib, myeloid, priority, conformational, dasatinib, journal, effect, non, erlotinib, sorafenib, lapatinib

Abstract

[No abstract available]

Más información

Título de la Revista: CURRENT PHARMACEUTICAL DESIGN
Volumen: 18
Número: 20
Editorial: BENTHAM SCIENCE PUBL LTD
Fecha de publicación: 2012
Página de inicio: 2851
Página final: 2851
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-84861738100&partnerID=40&md5=a8500ae3105f475628ec3210c037ddf5